Membrane-mediated fibrillation and toxicity of the tau hexapeptide PHF6

J Biol Chem. 2019 Oct 18;294(42):15304-15317. doi: 10.1074/jbc.RA119.010003. Epub 2019 Aug 22.

Abstract

The aggregation of the tau protein into neurofibrillary tangles is believed to correlate with cognitive decline in several neurodegenerative disorders, including Alzheimer's disease. Recent studies suggest that tau's interactions with the cell membrane could serve as a toxicity pathway and also enhance fibrillation into paired helical filaments (PHFs). Conformational changes associated with tau-membrane interactions are poorly understood, and their characterization could improve our understanding of tau pathogenicity. In this study, we investigated the molecular level structural changes associated with the interaction of the tau hexapeptide PHF6 with model lipid membranes and characterized the effects of these interactions on membrane stability and peptide fibrillation. We used two PHF6 forms, the aggregation-prone PHF6 with N-terminal acetylation (Ac-PHF6) and the non-aggregation prone PHF6 with a standard N terminus (NH3+-PHF6). We found that both PHF6 peptides are neurotoxic and exhibit similar membrane-mediated changes, consisting of: 1) favorable interactions with anionic membranes, 2) membrane destabilization through lipid extraction, and 3) membrane-mediated fibrillation. The rate at which these changes occurred was the main difference between the two peptides. NH3+-PHF6 displayed slow membrane-mediated fibrillation after 6 days of incubation, whereas Ac-PHF6 adopted a β-sheet conformation at the surface of the membrane within hours. Ac-PHF6 interactions with the membrane were also accompanied by membrane invagination and rapid membrane destabilization. Overall, our results reveal that membrane interactions could play a critical role in tau toxicity and fibrillation, and highlight that unraveling these interactions is important for significantly advancing the development of therapeutic strategies to manage tau-associated neurodegenerative diseases.

Keywords: Alzheimer disease; PHF6; Tau protein (Tau); amyloid; membrane structure; membrane-mediated fibrillation; neurodegeneration; paired helical filament; tauopathy; toxicity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Acetylation
  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism
  • Amino Acid Motifs
  • Cell Membrane / genetics
  • Cell Membrane / metabolism*
  • Humans
  • Neurofibrillary Tangles / genetics
  • Neurofibrillary Tangles / metabolism*
  • Peptides / genetics
  • Peptides / metabolism*
  • Peptides / toxicity
  • Protein Structure, Secondary
  • tau Proteins / chemistry
  • tau Proteins / genetics
  • tau Proteins / metabolism*
  • tau Proteins / toxicity

Substances

  • Peptides
  • tau Proteins